BeOne Medicines (ONC) Non Operating Income (2023 - 2025)

BeOne Medicines (ONC) has 3 years of Non Operating Income data on file, last reported at $3.0 million in Q3 2025.

• On a quarterly basis, Non Operating Income fell 71.54% year-over-year to $3.0 million in Q3 2025; TTM through Sep 2025 was $20.2 million, a 64.15% decrease from a year earlier, with the FY2024 full-year figure at $47.8 million, down 35.36% from the prior year.
• Non Operating Income for Q3 2025 stood at $3.0 million, down from $3.5 million in the prior quarter.
• Over the last five years, Non Operating Income for ONC reached as high as $26.6 million in Q3 2023 and fell as low as $3.0 million in Q3 2025.
• Historically, Non Operating Income has averaged $11.5 million across 3 years, with a median of $10.6 million in 2024.
• Across the five-year window, Non Operating Income tumbled 52.02% in 2024 and slumped 73.56% in 2025, its largest moves.
• Year by year, Non Operating Income stood at $16.3 million in 2023, then tumbled by 52.02% to $7.8 million in 2024, then tumbled by 61.21% to $3.0 million in 2025.
• Per Business Quant data, the three most recent Non Operating Income figures were $3.0 million in Q3 2025, $3.5 million in Q2 2025, and $5.8 million in Q1 2025.